secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001628280-25-031818
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Avalo stockholders elect eight directors, approve say-on-pay and auditor ratification at 2025 annual meeting
--------------------------------------------------------------------------------

- All eight director nominees elected; top vote-getter Michael Heffernan with 8,022,534 shares for.
- Say-on-pay advisory resolution approved with 8,003,142 votes in favor (99.7% of votes cast).
- Ratification of Ernst & Young as independent auditor for FY 2025 passed with 9,782,455 votes for.
- Approximately 90% of outstanding shares (9.79M of 10.83M) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828025031818/0001628280-25-031818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828025031818/avtx-20250617.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-031818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer